A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.

Genome Med · 2022 · PMC9476269 · PMID 36109798

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

[ 71 ] showed a trend towards higher frequency of CD8 inflamed tumors in the poor outcome group, but CD8 inflamed tumors are also present in the intermediate and even good prognostic group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.